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Background: Poor asthma control can lead to exercise-induced bronchoconstriction (EIB), but the relationship between subjective
disease control and EIB is unclear. No studies have compared asthma control test (ACT) scores of children with those of their
parents regarding EIB. We assessed whether ACT scores predict the occurrence of EIB in two age groups. We also evaluated ACT
scores and objective measures as explanatory variables for airway response to exercise.
Methods: Patients (71 aged <12 years, 93 aged ≥12 years) and their parents completed an ACT questionnaire separately. Current
therapy, skin prick testing and spirometry at baseline and after exercise were assessed. EIB was defined as a fall in FEV1 of at
least 12% from baseline. Sensitivity and specificity for cut-off values of ACT scores predictive of EIB were plotted, and the Area
Under Curve (AUC) was described.
Results: Atopy and current therapy were similarly frequent. EIB was observed in 23.9% of children aged <12 years and in 33.3%
aged ≥12 years. EIB occurrence in subjects previously scored as having full control (25), partial control (20‐24) and no control (<20)
varied according to the age group and responder. Percentages of EIB cases increased as ACT scores decreased in children aged ≥12
years alone (child ACT scores, 25: 21.9%, 20-24: 31.1%, <20: 62.5%, p=0.017). Plots for ACT scores as predictors of EIB  yielded low
non‐significant AUC values in children aged <12 years; by contrast, moderate AUC values emerged in children aged ≥12 years (child:
0.67, p=0.007; parent: 0.69, p=0.002). Sensitivity of ACT scores below 20 as a predictor of EIB was low in older children (child:
32.3%, parent: 22.6%), whereas specificity was high (child: 90.3%, parent: 93.5%). Multiple regression analysis with percent fall in
FEV1 as dependent variable included FEV1/FVC%, ACT child score and gender in the prediction model ( r=0.42, p=0.000).
Conclusion: ACT scores are a more effective means of excluding than confirming EIB in asthmatic patients aged ≥12 years; their
predictive value decreases in younger patients. ACT scores together with lung function may help to predict airway response to
exercise. New tools for pediatric asthma assessment may optimize this association.
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criteria to obtain exercise testing in our institution are either to support a diagnosis of asthma or to assess asthma control;
identification of EIB enables us to adjust asthma therapy and, through counseling on preventive measures, to encourage patient
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participation in motor activities. We routinely assess atopy to classify the asthma phenotype, whose therapeutic implications (e.g.
the allergic phenotype respond better to therapy with inhaled corticosteroids) are stated in international asthma guidelines (10).
   
Please detail the consent procedure used for human participants or for animal owners. If not applicable, please state this.
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Only children with mild to moderate asthma and willing to participate were invited. None of these subjects had had any
respiratory disorders in the previous 4 weeks.
In re
view
 1 
 
 Asthma control test (ACT) and bronchial challenge with exercise in 1 
pediatric asthma. 2 
Salvatore Tripodi
1
,
 
Mario Barreto
2
*, Andrea Di Rienzo-Businco
1
, Oriano Grossi
1
, Ifigenia Sfika
1
, 3 
Giovanni Ragusa
1
, Martina Campisano
2
 and Stefano Miceli-Sopo
3
. 4 
1
 Pediatric Department & Allergy Pediatric Unit, Sandro Pertini Hospital, Rome, Italy; 
2 
Pediatric 5 
Unit Sant'Andrea Hospital, NESMOS Department, Faculty of Medicine and Psychology, 6 
“Sapienza” University, Rome, Italy; 3Department of Pediatrics, Catholic University of Rome, 7 
Rome, Italy.      8 
 9 
*Correspondence to: 10 
Mario Barreto, MD 11 
U.O.C. di Pediatria, Ospedale Sant’Andrea 12 
Via di Grottarossa 1035-1039 13 
00189 Roma (Italia) 14 
Tel: +39/0633775279 15 
Fax: +39/0633775941 16 
e-mail: mario.barreto@uniroma1.it 17 
 18 
 19 
 20 
Short/running title: ACT and EIB in children 21 
Number of words: 3593. Number of figures: 2 22 
  23 
In re
view
 2 
 
 24 
Introduction 25 
 26 
Exercise-induced bronchoconstriction (EIB) is a transient narrowing of the airways that affects 40 27 
to 90% of asthmatic children and adolescents (1-3). Prevention of this condition, which is essential 28 
in young patients because EIB prevents their participation in vigorous activities (4), can be achieved 29 
by means of appropriate asthma therapy (5, 6). As exercise-induced symptoms cannot always 30 
diagnose EIB, this pathology is best documented objectively using a bronchial challenge (3, 7).  31 
Exercise testing is a suitable bronchial challenge for children; exercise-induced hyperpnea 32 
indirectly provokes airway narrowing through local dehydration and hyper-osmolarity, followed by 33 
the release of several inflammatory mediators (8). As with other indirect challenges, EIB is at least 34 
partially inhibited by inhaled corticosteroids (8, 9); hence, its detection reflects active airway 35 
inflammation and helps when therapy needs to be adjusted and the disease monitored (7, 8).  36 
Management of asthma, as stated by international guidelines, is based on the assessment of disease 37 
control (10, 11). A useful numerical method to evaluate the level of disease control is the asthma 38 
control test (ACT), which includes questions regarding symptoms, medication use and self-assessed 39 
disease control (12). The ACT questionnaire has been validated for subjects over 12 years of age 40 
(13). An ACT version for younger children (C-ACT) has also been validated for subjects between 4 41 
and 11 years of age (14). 42 
Questionnaires for assessing asthma control in children provide useful information for research 43 
study purposes, though their usefulness in routine clinical practice is still debated (15). One 44 
important limitation is the discordance between asthma symptoms reported by the children 45 
themselves and those described by the parents (16). These contrasting reports may, however, 46 
contribute to our understanding of disease control in such patients as estimated on the basis of 47 
outcomes from bronchial challenge with exercise.  48 
Few studies have tested the relationship between the occurrence of EIB and the degree of asthma 49 
control as assessed by questionnaires that yield contrasting results (17-19), and no studies have 50 
compared ACT scores of children with those of their parents regarding EIB. A better knowledge of 51 
this issue may shed light on the role played by these scores in the monitoring of asthma either on 52 
their own or together with objective measures such as lung function and exercise testing. 53 
The aim of our study was to assess the ability of ACT scores (yielded by both children and their 54 
parents/guardians) to predict the occurrence of EIB in two groups of asthmatic patients divided 55 
using an age cut-off of 12 years. We also evaluated ACT scores and objective measures (baseline 56 
lung function, atopy and anthropometric characteristics) as potentially explanatory variables for the 57 
airway response to exercise in the whole population. 58 
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Materials and Methods 60 
 61 
Subjects 62 
We assessed 173 asthmatic outpatients aged 7-20 years who came to our Pediatric Unit (S. P. 63 
Hospital) for a follow-up visit from February 2008 to April 2009. Asthma was classified according 64 
to Global Initiative for Asthma guidelines (10). Subjects with mild to moderate asthma were invited 65 
to participate; they had previously documented bronchial reversibility (a post-bronchodilator FEV1 66 
increase ≥12%) or a positive response to exercise challenge (fall in FEV1 ≥12%). Current asthma 67 
therapy was recorded. Subjects who had had any respiratory disorders in the previous 4 weeks were 68 
excluded. Informed consent was obtained from the children’s parents. This study was nested within 69 
a previous study (20) that was approved by the ethics committee and the ethics committee indicated 70 
that no extra approvals were required (appendix). In our specialized Unit (Allergy & Pulmonology 71 
Section), bronchial challenge with exercise and allergen skin prick testing are included as routine 72 
tests. The clinical criteria to obtain exercise testing in our institution are either to support a 73 
diagnosis of asthma or to assess asthma control; identification of EIB enables us to adjust asthma 74 
therapy and, through counseling on preventive measures, to encourage patient participation in motor 75 
activities. We routinely assess atopy to classify the asthma phenotype, whose therapeutic 76 
implications (e.g. the allergic phenotype respond better to therapy with inhaled corticosteroids) are 77 
stated in international asthma guidelines (10).     78 
 79 
Study design 80 
All measurements were performed in a single session. Before exercise testing, current respiratory 81 
symptoms and asthma medication were assessed and patients underwent a medical visit. Parents and 82 
children completed an ACT questionnaire on how the patient’s disease was being controlled 83 
separately; children also underwent a skin prick test at least one hour before the exercise challenge. 84 
The lung function laboratory personnel were unaware of the questionnaire results. Subjects were 85 
divided in two different age groups: below 12 years and 12 years or older.  86 
 87 
ACT questionnaire 88 
The ACT is a validated, 5-item, patient-completed measure of asthma control with a four-week 89 
recall period. By summing the five item scores, three levels of control are identified: scores from 5 90 
to 19 indicate uncontrolled asthma; scores from 20 to 24 indicate partially-controlled asthma and a 91 
score of 25 indicates fully-controlled asthma (12, 13). To compare self-assessed control and parent-92 
perceived asthma control, both patients aged at least 12 years and their parents were asked to 93 
complete the ACT questionnaire blindly. Children aged below 12 years (7.3-11.9 years) completed 94 
the ACT questionnaires with the help of the interviewer (whereas their parents completed the ACT 95 
blindly) because younger children often need guidance when answering questions (14); the Italian 96 
version of the C-ACT was not available at that time.  97 
 98 
Skin Prick Test 99 
The skin prick test was performed using commercial allergens (ALK-Abellò, Milan, Italy) for 100 
several common inhaled allergens (Dermatophagoides pteronissinus and D. farinae, cat and dog 101 
fur, Alternaria alternata, Phleum pratense, Cynodon dactylon, Plantago lanceolata, Chenopodium 102 
album, pellitory, mugwort, ragweed, Olea europaea, cypress, birch, plane, elm) and food allergens 103 
(milk, egg white, egg yolk, soybean, tomato, codfish, shrimp, wheat, peach and peanut). Histamine 104 
0.1 mg/mL and glycerol solution were used as positive and negative controls, respectively. Morrow-105 
Brown needles were used to prick the skin, and the wheal reactions were read after 15 min. A wheal 106 
≥3 mm after subtraction of the negative control was regarded as positive (21). The sum of positive 107 
skin reactions corrected by the histamine wheal size was termed Prick Index (22). 108 
 109 
Spirometry and exercise testing 110 
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Spirometry was performed with a Pony FX device (Cosmed, Rome, Italy) in the seated position at 111 
baseline and after exercise, as recommended (23). Duplicate measurements were obtained from at 112 
least three acceptable FVC maneuvers (23) and expressed as a percentage of predicted values (24). 113 
Subjects performed an incremental treadmill exercise test as described elsewhere (25), running at 6 114 
km/h with a pendant 10% until they reached a heart rate of between 80% and 90% of the maximum 115 
predicted (220 minus age in years), according to ATS recommendations for exercise challenge tests 116 
in children (26, 27). Room temperature was kept in the 20-24°C range and ambient-relative 117 
humidity between 50% and 60%. Spirometry was repeated 5, 10, 15, 20 and 30 minutes post-118 
exercise. Exercise response was calculated as the maximum post-exercise fall in FEV1 expressed as 119 
a percentage from baseline. EIB was defined as a fall in FEV1 of at least 12% (27).  120 
 121 
Statistical analysis 122 
Continuous variables were assessed for normal distribution (Kolmogorov-Smirnov  test) and 123 
expressed consequently as  means ± SD or as medians and interquartile (IQR) ranges; categorical 124 
variables were given as numbers and percentages. Non-parametric Mann-Whitney tests were used 125 
for unpaired comparisons between two groups, and contingence tables (χ2 with Fisher’s correction) 126 
to compare frequencies between categorical variables. Cohen’s Kappa coefficient was used to 127 
estimate the agreement between two ACT  raters (child and parent), with κ=1 indicating perfect 128 
agreement and κ ≤0 indicating that inter-rater agreement is less than that expected by chance (28). 129 
Agreement for intermediate κ values was defined as  “poor-to-fair”(< 0.40), “moderate” (0.41 to 130 
0.60), “substantial” (0.61 to 0.80) and “almost perfect”(0.81 to 1.0) (27).   131 
The graphical relationship between sensitivity and 1-specificity for all possible cut-off values of 132 
ACT scores predictive of EIB was plotted as a Receiver Operating Characteristic (ROC) curve, and 133 
the Area Under Curve (AUC) was described. The sample size required for a ROC curve was 134 
calculated as described by Hanley and McNeil (29); the number of cases required for an assumed 135 
type I error (α: significance) of 0.05, a type II error (β: 1-power) of 0.2, an expected AUC 0.70, a 136 
null hypothesis value 0.5 and a ratio of sample sizes in negative (without EIB)/positive (EIB) 137 
groups of 2 was 76.  The non-parametric method of DeLong et al. was used to compare the areas 138 
under the two ROC curves (30).  139 
Pearson’s or Spearman’s rho tests were used for correlations as per data distribution type. Stepwise 140 
multiple linear regression was performed, with the maximum fall in FEV1  as the dependent 141 
variable against potential explanatory variables selected on the basis of either statistically 142 
significant correlations with the dependent variable or significant differences between categorical 143 
variables according to the fall in FEV1, as described elsewhere (31). A MedCalc software (MedCalc 144 
bvba, Ostend, Belgium) was used for sample size calculation and comparison between the ROC 145 
curves; all the remaining statistical analyses were performed using the SPSS software (version 19; 146 
SPSS Inc., Chicago, Illinois, USA). Two-tailed p values of less than 0.05 were considered 147 
statistically significant. 148 
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Results 150 
 151 
Nine of the 173 asthmatic subjects who were invited to participate were excluded: 7 were 152 
uncooperative during the spirometry or exercise challenge, while 2 refused the skin prick test. The 153 
remaining 164 children, who were divided in two age groups (71 aged below 12 years, 93 aged 12 154 
years or above), completed all the measurements. The frequency of atopy and current anti-155 
inflammatory therapy with inhaled corticosteroids (ICs) or oral Montelukast was similar in both age 156 
groups [patients <12 years, atopy:  63 (88.7%), asthma therapy: 19 (26.8%); patients ≥12 years, 157 
atopy: 89 (95.7%), asthma therapy: 21 (22.6%) (Table 1). 158 
 159 
Agreement between child and parent ACT scores 160 
Scores yielded by the ACT completed by children differed from those of the ACT completed by 161 
their parents, particularly in the group aged below 12 years. The percentages of concordant child vs. 162 
parent responses for all the ACT score intervals (uncontrolled:<20, partially controlled: 20-24, fully 163 
controlled: 25) were 56.3% in the younger group [Kappa (SE) agreement 0.295 (0.097), p=0.000] 164 
and 75.3% in the older group [Kappa (SE) agreement 0.598 (0.073), p=0.000]. According to the 165 
Kappa values, agreement between the younger age group and their parents was “poor-to-fair”, 166 
whereas agreement between the older age group and their parents was “moderate” (Table 2). 167 
 168 
Occurrence of EIB 169 
A post-exercise fall in FEV1 of at least 12% (EIB) was observed in 17 (23.9%) of the children aged 170 
below 12 years and in 31 (33.3%) of the children aged 12 years or above. Subjects with EIB were 171 
more frequently treated with asthma medication and had lower baseline lung function and ACT 172 
scores than children without EIB, though differences for ACT scores were significant in the older 173 
group alone (Table 3). 174 
 175 
Distribution of EIB according to levels of asthma control  176 
Occurrence of EIB in subjects previously scored as having full control (25), partial control (20-24) 177 
and no control (<20) varied according to the age group and responder (child or parent). The 178 
percentages of EIB cases divided according to each disease-control level (positive/negative + 179 
positive x 100) did not increase as ACT scores decreased in younger children, whereas they did 180 
increase in children aged 12 years or above (child ACT scores, 25: 21.9%, 20-24: 31.1%, <20: 181 
62.5%, p=0.017; parent ACT scores, 25: 24.4%, 20-24: 34.1%, <20: 63.6%, p=0.049); (Figure 1, A-182 
B). 183 
 184 
ACT scores as predictors of occurrence of EIB according to age group 185 
Sensitivity and specificity plots for cut-off points of the ACT scores as predictors of EIB  (ROC 186 
curves) yielded low AUC values in the group aged below 12 years (child: 0.52, p=0.814; parent: 187 
0.59, p=0.255); by contrast, moderate AUC values emerged in the group aged 12 years or above 188 
(child: 0.672, p=0.007; parent: 0.695, p=0.002). The sensitivity of ACT scores below 20 (loss of 189 
control) as a predictor of EIB was low in the older age group, particularly in parents (child: 32.3%, 190 
parent: 22.6%), whereas specificity was high (child: 90.3% , parent: 93.5%). The sensitivity of ACT 191 
scores below the intermediate values within the 20-24 range (partial control) as predictors of EIB 192 
improved (ACT<23, child: 54.8%, parent: 58.1%) whereas the specificity declined, particularly in 193 
children (ACT<23, child: 74.2%, parent: 83.9%); (Table 4). However, no significant differences 194 
were detected between older children and their parents in the ROC curves (difference between areas 195 
0.0234, 95% CI -0.0732 to 0.120, p=0.6349); (Figure 2, A-B and Table 4). 196 
 197 
Assessment of influencing factors on airway response to exercise in the whole population. 198 
The percent fall in FEV1 following exercise correlated with low baseline lung function and ACT 199 
scores but did not correlate with atopy scores for inhalant or food allergens (Table 5). A multiple 200 
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regression analysis with the percent fall in FEV1 as the dependent variable against potential 201 
explanatory variables included FEV1/FVC%, ACT child score and gender (male=0, female=1) in 202 
the prediction model ( r=0.42, p=0.000): 203 
% fall in FEV1= -85.208+(0.705 x FEV1/FVC%) + (ACT child x 0.739) + (-4.880 x gender). 204 
  205 
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Discussion 206 
 207 
We found that ACT scores, as completed by children or their parents, were moderately good 208 
predictors of EIB in our group of asthmatic patients aged 12 years and older but poor predictors of 209 
EIB in patients under 12 years of age. Subjective information from the ACT was used to 210 
complement data obtained from objective measures, such as baseline lung function and gender, to 211 
explain the airway response to exercise in the whole population. 212 
We analyzed ACT scores from patients above and below the 12-year-old cut-off  separately to 213 
ensure that questionnaires were applied to the recommended age range, at least for the older age 214 
group. Since an Italian version of the children ACT (C-ACT) for children under 12 years of age was 215 
not available when we conducted our study, we asked both children and their parents to complete 216 
the questionnaires in both age groups. Not only did we expect the parent’s perception of their 217 
children’s asthma control to compensate for the inadequacies of the ACT, but we were also 218 
interested in examining the inter-rater agreement (child vs. parent) of the questionnaire scores. 219 
Since agreement for the ACT score intervals between young patients and their parents was, 220 
according to the Kappa values, “poor-to-fair”, our results indicate that asking parents to complete 221 
the ACT questionnaires cannot be considered a reliable surrogate of the C-ACT in asthmatic 222 
children younger than 12 years of age. 223 
The relationship between ACT scores and EIB has rarely been assessed in asthmatic children, 224 
particularly in those aged 12 years and above. No studies have compared the value of patients’ and 225 
parents’ responses to the ACT as a predictor of EIB. The relationship between the ACT and EIB has 226 
previously been reported for a group that included pediatric patients whose age ranged widely (17). 227 
Rapino et al. assessed self-completed ACT questionnaires in 81 asthmatic children aged 6-17 years 228 
who performed an exercise challenge; EIB (defined as a fall in FEV1 greater than 10%) was no 229 
more frequent in subjects whose score indicated uncontrolled asthma (ACT<20); moreover, 230 
subjects with fully-controlled asthma (ACT=25) more frequently had EIB than subjects with 231 
partially-controlled and uncontrolled asthma together (36.0% vs 23.5%, p<0.01) (17). In contrast to 232 
their study, we defined EIB as a fall in FEV1>12% and analyzed our population according to age 233 
groups rather than as a whole. Our results are in keeping with those of Rapino et al. solely for our 234 
group of patients aged below 12 years. By contrast, the likelihood of EIB increased as ACT scores 235 
decreased in our patients aged 12 years or above regardless of whether it was the children or their 236 
parents who completed the ACT. Our results pointing to the low sensitivity and high specificity of 237 
ACT scores as predictors of  EIB in cases of uncontrolled asthma in our older age group suggest 238 
that the ACT is more effective as a means of excluding, rather than confirming, EIB.  239 
Possible correlations between the EIB and other questionnaires, such as the C-ACT and asthma 240 
control questionnaire (ACQ), have also been assessed (18, 19). Chinellato et al. found a moderately 241 
good discriminatory power of the C-ACT total score as a predictor of EIB in young children aged 4-242 
11 years, particularly as a predictor of the absence of EIB in subjects rated above 19, i.e. with 243 
partial-to-full disease control (18). Our study did not include very young children (4-6 years), 244 
whose recall difficulty beyond one day is well known (14). The frequency of EIB in our young 245 
patients who rated themselves 20 or higher  (11/54=20.4%) was similar to that reported by 246 
Chinellato et al. (14/72=19.4%). Moreover, an ACT score <20 in our young patients was a 247 
moderately good predictor of EIB (sensitivity 35%, specificity 80%), whereas a score from 20 to 24 248 
(e.g. <23) was a poor predictor of EIB. Consequently, no significant areas were detected when the 249 
ROC curves for EIB and for the ACT scores yielded by our young patients and their parents were 250 
compared. 251 
We used the ACT questionnaire without adding questions on exercise-induced symptoms.  Unlike 252 
the ACT, some questionnaires in young children (e.g. TRACK and C-ACT) inquire about activity 253 
I  
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limitation (18, 32). However, Chinellato et al. did not detect any relationship between scores for the 254 
single C-ACT question on exercise-related problems and the degree of EIB in their young subjects, 255 
while Rapino et al. found that a direct question on exercise-induced symptoms (in addition to the 256 
ACT questionnaire) did not help to discriminate subjects with EIB (17). These reports further 257 
support the notion that self-reported exercise-induced symptoms are not very reliable as a means of 258 
predicting EIB (7, 27). 259 
In contrast to studies based on the ACT and C-ACT,  Madhuban et al. found no relationship 260 
between the categorical ACQ and the occurrence of EIB in 200 asthmatic children; the authors 261 
pointed out that 41% of their children with well-controlled asthma, according to the ACQ, had EIB, 262 
thus implying that their asthma was not well controlled  (19). Although previous results are not 263 
encouraging, the potential usefulness of questionnaires as a means of ruling out airway hyper-264 
responsiveness to exercise cannot be excluded. 265 
An interesting question raised by our results is why ACT scores obtained from parents differ from 266 
those of children, and which are more reliable. A third of the children who responded as having “no 267 
asthma control” (<20) had EIB, whereas a quarter of the parents’ scores <20 predicted that their 268 
child had EIB. When the ACT cut-off values were raised to <23 (which includes low scores of 269 
“partial” asthma control plus “no asthma control”), the parents’ scores slightly improved prediction 270 
of EIB if compared with those of their children. This discordance suggest that some parents play 271 
down the effectiveness of disease control in their children. As AUCs did not differ between children 272 
and their parents, we are unable to recommend the use of parent-completed ACT responses for the 273 
prediction of EIB in their children aged 12 years or above. 274 
ACT scores obtained from children responses together with the baseline FEV1/FVC% and gender 275 
explained the change in FEV1 following exercise in our overall population. Reports on the 276 
relationship between baseline lung function and gender in cases of post-exercise airway narrowing 277 
are contrasting (2, 7, 33-36). Baseline FEV1 did not explain the degree of EIB in two studies (2, 33), 278 
whereas the baseline FEV1/FVC did in another report, which is in keeping with our results (34). The 279 
prevalence of EIB was slightly higher in females than in males in some studies that assessed 280 
unselected populations (7, 36). Males accounted for about two thirds of our asthmatic population 281 
and for 60% of the EIB cases, a fact that might have biased our results. Another bias could be 282 
caused by the fact that subjects who performed exercise testing successfully may not represent the 283 
entire asthmatic population; indeed, our selection criteria implied that subjects unable to cooperate 284 
(e.g. young age, refusal/inadequate performance of testing procedures) were excluded. Nonetheless, 285 
our data suggest that questionnaire-based assessments may be used to complement objective 286 
measurements to predict asthma control according to an exercise bronchial challenge.  287 
In conclusion, ACT scores are a more effective means of excluding than of confirming EIB if used 288 
in asthmatic patients aged 12 years and older; their predictive value decreases in younger patients, 289 
even when the ACT questionnaire is completed by their parents. Subjective information gleaned 290 
from the ACT together with objective measures, such as lung function and gender, may help to 291 
predict the airway response to exercise, and consequently to estimate disease control and adjust 292 
therapy accordingly. Further pediatric studies, preferably designed according to new pediatric 293 
asthma assessment tools, are warranted to optimize subjective measures of asthma control and to 294 
assess their relationship with EIB. 295 
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Legends 420 
Figure 1. Percentages of EIB cases according to disease-control level: fully-controlled (25), 421 
partially-controlled (20-24) and uncontrolled (<20). A: patients aged <12 years, B: patients 422 
aged ≥ 12 years (*p=0.017 and p=0.049 for child and parent ACT, respectively). 423 
Figure 2. Receiver Operating Characteristic (ROC) curves for ACT scores as predictors of 424 
EIB. 2-A: Patients aged under 12 years; areas under curves (AUCs): child: 0.52, p=0.814; 425 
parent: 0.59, p=0.255. 2-B: Patients aged ≥12 years; AUCs: child: 0.67, p=0.007; parent: 0.69, 426 
p=0.002; thick arrows (child) and thin arrows (parent) indicate predictive values for ACT 427 
scores below 20, 23 and 25 (detailed in Table 4). 428 
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Table 1. Demographics and measurements in the asthmatic patients divided by age group. 
 
 Age < 12 years (n=71) Age ≥ 12 years (n=93) 
 
Males, n ( %) 48 (67.6) 63 (67.7) 
Age, yr 10.0 ± 1.2 14.3 ± 1.8** 
Height, cm 142.0 ± 8.2 163.0 ± 10.1** 
Weight, Kg 39.2 ± 9.6 60.5 ± 11.8** 
Atopy,  n (%) 63 (88.7) 89 (95.7) 
Prick index, inhalants
1
  4.1 ± 2.8 4.3 ± 2.5 
Prick index, foods
2
 0.7 ± 1.2 0.8 ± 1.1 
Passive Smoke, n (%) 26 (36.6) 25 (26.9) 
Therapy, n (%)
3
 19 (26.8) 21 (22.6) 
 ICs 17 (23.9) 18 (19.4) 
 Montelukast 6 (8.5) 10 (10.8) 
FEV1, % predicted 99.4 ± 13.1 102.5 ± 13.1 
FVC, % predicted 105.1 ± 11.7 107.9 ± 13.6 
FEV1/FVC, %  85.4 ± 7.5 83.6 ± 6.7 
PEF % predicted 104.6 ± 16.4 108.9 ± 19.4 
FEF25-75, % predicted 79.9 ± 24.4 83.7 ± 22.6 
ACT child  22.0 (20.0 - 24.0) 23.0 (21.0 - 25.0)* 
ACT parent 23.0 (20.0 - 25.0) 24.0 (22.0 - 25.0) 
Frequencies are expressed as number and percentage; continuous variables are expressed as 
arithmetic mean ± standard deviation or as median (interquartile range).  
* p<0.05 and **p<0.01 vs subjects aged < 12 years. 
Prick index 
(1,2)
 : sum of allergen skin-wheal reactions for common inhalants or foods, corrected 
by the histamine wheal size (mm).
 3
Current therapy with inhaled corticosteroids (ICs) and/or 
montelukast. 
EIB was defined as a post-exercise fall in FEV1 ≥ 12% from baseline. ACT: Asthma Control Test 
score. 
 430 
 431 
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Table 2. Agreement between child and parent ACT scores according to age group. 
 ACT Parent 
<12 years (n=71) ≥12 years (n=93) 
 
ACT 
child 
 
 
 <20 20-24 25 <20 20-24 25 
<20 8 9 0 10 5 1 
20-24 3 21 14 1 32 12 
25 0 5 11 0 4 28 
Numbers of concordant child- vs- parent responses for intervals of ACT scores are given in bold 
type.  
<12 years: 8+21+11/71 (56.3%), Kappa (SE) agreement 0.295 (0.097), p=0.000. 
≥12 years: 10+32+28/93 (75.3%) , Kappa (SE) agreement 0.598 (0.073), p=0.000. 
 433 
 434 
 435 
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Table 3. Characteristics, measurements and ACT scores according to presence of exercise-induced 
bronchoconstriction (EIB) in the asthmatic patients divided by age group. 
 Age < 12 years Age ≥ 12 years 
 Without EIB 
(n=54) 
EIB 
 (n=17) 
Without EIB 
(n=62) 
EIB 
 (n=31) 
Males, n ( %) 39(72.2) 9 (52.9) 43(69.4) 20 (64.5) 
Age, yr 10.0 ± 1.2 9.7 ± 1.2 14.4 ± 1.8 14.1 ± 2.0 
Height, cm 141.9 ± 8.4 142.1 ± 7.9 163.9 ± 10.3 161.1 ± 9.3 
Weight, Kg 39.8 ± 10.1 37.4 ± 8.0 60.7 ± 11.8 60.1 ± 12.1 
Atopy, n (%) 47 (87.0) 16 (94.1) 58 (93.5) 31(100.0) 
Prick index, inhalants
1
  4.3 ± 2.8 3.7 ± 2.5 4.7 ± 2.7 3.7 ± 2.2 
Prick index, foods
2
 0.8 ± 1.3 0.4 ± 0.7 0.8 ± 1.2 0.7 ± 1.0 
Passive Smoke, n (%) 20 (37.0) 6 (35.3) 18 (29.0) 7 (22.6) 
Therapy, n (%)
3
 12 (22.2) 7 (41.2) 7 (11.3) 14 (45.2)** 
 ICs 10 (18.5) 7 (41.2) 6 (9.7) 12 (38.7)** 
 Montelukast 5 (9.3) 1 (5.9) 3 (4.8) 7 (22.6)* 
FEV1, % predicted 101.6 ± 12.3 92.6 ± 13.6* 104.3 ± 13.8 98.9 ± 11.1* 
FVC, % predicted 105.8 ± 12.2 102.9 ± 9.9 108.3 ± 13.9 106.9 ± 13.3 
FEV1/FVC, %  86.5 ± 6.8 81.8 ± 8.7* 84.4 ± 6.4 81.9 ± 7.0 
PEF % predicted 106.3 ± 17.1 99.5 ± 13.1 111.0 ± 19.0 104.8 ± 19.8 
FEF25-75, % predicted 82.9 ± 24.4 70.6 ± 22.7 87.0 ± 23.2 76.9 ± 20.1* 
ACT child  22.0 (20.0 - 24.0) 22.0 (19.0-25.0) 24.0 (22.0-25.0) 22.0 (18.0-24.0)** 
ACT parent 23.0 (20.0 - 25.0) 22.0 (20.0-24.0) 24.5 (23.0-25.0) 21.0 (20.0-25.0)** 
Frequencies are expressed as number and percentage; continuous variables are expressed as arithmetic 
mean ± standard deviation or as median (interquartile range).  
* p<0.05 and **p<0.01 vs subjects without EIB from the same group. 
Prick index 
(1,2)
 : sum of allergen skin-wheal reactions for common inhalants or foods, corrected by the 
histamine wheal size (mm).
 3
Current therapy with inhaled corticosteroids (ICs) and/or montelukast. 
EIB was defined as a post-exercise fall in FEV1 ≥ 12% from baseline. ACT: Asthma Control Test score.  
 438 
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Table 4. Prediction of EIB in subjects with loss of asthma control (ACT score <20) and 
subjects scored below full disease control (<23, <25).  
 Age < 12 yr (n=71) Age ≥ 12 yr (n=93) 
ACT score child  <20 <23 <25 <20 <23 <25 
 Sensibility 35.3 52.9 70.6 32.3 54.8 77.4 
 Specificity 79.6 46.3 20.4 90.3 74.2 40.3 
 PPV 35.3 23.7 21.8 62.5 51.5 39.3 
 NPV 79.6 75.8 68.7 72.7 76.7 78.1 
       
ACT score parent  <20 <23 <25 <20 <23 <25 
 Sensibility 17.6 52.9 82.3 22.6 58.1 67.7 
 Specificity 85.2 59.3 40.7 93.5 83.9 50.0 
 PPV 27.3 29.0 30.4 63.6 64.3 40.4 
 NPV 76.7 80.0 88.0 70.7 80.0 75.6 
EIB: exercise-induced bronchoconstriction (post-exercise fall in FEV1 ≥ 12% from baseline). ACT: 
asthma control test. PPV: positive predictive value; NPV: negative predictive value. 
 441 
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Table 5. Spearman’s Rho correlations with the post-exercise fall in FEV1 in the whole 
population (n=164 asthmatic children). 
Variable Correlation (r) P value 
Age, yr -0.005 0.945 
Height, cm -0.009 0.913 
Weight, Kg -0.020 0.803 
Prick index, inhalants
1
 0.138 0.102 
Prick index, foods
2
 -0.031 0.709 
FEV1, % 0.166 0.033 
FVC, % 0.017 0.824 
FEV1/FVC, % 0.169 0.030 
PEF % 0.158 0.043 
FEF25-75, % 0.162 0.038 
ACT child  0.141 0.072 
ACT parent 0.186 0.017 
ACT: Asthma Control Test score. Prick index
(1,2)
 : sum of allergen skin-wheal reactions for 
common inhalants or foods, corrected by the histamine wheal size (mm). 
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